Coronavirus | CFTRI to sequence SARS-CoV-2 genome
[ad_1]
As a part of varied initiatives in the direction of mitigating COVID-19, CSIR-Central Food Technological Research Institute (CFTRI) signed an MoU with Clevergene, a Bengaluru-based firm, for sequencing the SARS-CoV-2 genome.
It is predicted that the examine would supply insights into the virus’s genome adjustments (mutations), evolution, epidemiology, and supply an understanding of the spatial and temporal info on an infection dynamics of the SARS-CoV-2.
Under the MoU, the event of novel diagnostics and vaccines for COVID-19 are envisaged, in accordance to the institute. CSIR-CFTRI has established a COVID-19 Testing Centre in Mysuru and a mean of 1,000 samples are examined each day.
CFTRI can also be engaged on the event of novel dipstick and aptamer-based diagnostics in collaboration with personal events. Clevergene is a expertise firm providing genomics companies for contract analysis and genetic diagnostics, a launch mentioned right here.
The MoU was exchanged between B. Manohar, Chief Scientist and Adviser (M and A), and Tony Jose, Co-Founder, and CEO, Clevergene.
A letter from the Editor
Dear subscriber,
Thank you!
Your assist for our journalism is invaluable. It’s a assist for reality and equity in journalism. It has helped us maintain apace with occasions and happenings.
The Puucho has all the time stood for journalism that’s within the public curiosity. At this tough time, it turns into much more vital that we’ve entry to info that has a bearing on our well being and well-being, our lives, and livelihoods. As a subscriber, you aren’t solely a beneficiary of our work but in addition its enabler.
We additionally reiterate right here the promise that our workforce of reporters, copy editors, fact-checkers, designers, and photographers will ship high quality journalism that stays away from vested curiosity and political propaganda.
Suresh Nambath
[ad_2]
